Our study demonstrated that DCQD could protect the intestinal barrier by reducing the production of inflammatory factors such as HMGB1, RAGE and TNF-α in the intestine; it could reduce their translocation through the intestinal lymphatic pathway and inhibit the inflammatory response induced by HMGB1 to treat SAP-ALI (Figure 8). The gene discussed is TNF; the disease is acute respiratory distress syndrome.